A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...
13d
Healthshots on MSNFuture Perspectives and Challenges in Recombinant Antibody DevelopmentRecombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...
From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...
In this webinar, Daryl Cole will share insights into the high-throughput screening and analysis of antibody binding and functional characterization.
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
The researchers found that when the anti-cancer antibody binds to P-cadherin ... be pinched off and sucked into the cell as a tiny bubble. The whole P-cadherin/antibody/drug complex is then sent to a ...
Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...
Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 biparatopic antibody-drug ...
Now, a new class of drugs may be emerging to challenge the dominance of these first generation checkpoint inhibitors. Experts said a certain type of bispecific antibody seems to have hit upon a ...
("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for Drug Evaluation (CDE) of the National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results